IDEXX Laboratories, Inc., a leading innovator in the veterinary diagnostics industry, is headquartered in the United States. Founded in 1983, the company has established itself as a key player in the development of diagnostic products and services for animal health, water testing, and dairy testing. With a strong presence in North America, Europe, and Asia, IDEXX is renowned for its advanced diagnostic technologies, including the IDEXX VetLab® suite and the SNAP® test platform. The company’s commitment to enhancing animal health and welfare is reflected in its core offerings, which include laboratory services, point-of-care diagnostics, and software solutions. IDEXX's unique approach combines cutting-edge technology with a deep understanding of veterinary needs, positioning it as a trusted partner in the industry. Notable achievements include a robust market share and recognition for its contributions to improving pet care and public health.
How does Idexx Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Idexx Laboratories's score of 30 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, IDEXX Laboratories reported total greenhouse gas emissions of approximately 38,697,000 kg CO2e, with Scope 2 emissions accounting for about 20,236,000 kg CO2e. This marks an increase from 2023, when total emissions were about 35,015,000 kg CO2e, with Scope 2 emissions at approximately 18,557,000 kg CO2e. The company has set an ambitious target to reduce its Scope 1 and 2 emissions by 37.8% by 2030, starting from a baseline established in 2021. IDEXX's emissions data does not include Scope 3 emissions, and there is no reported data inherited from a parent company. The company is committed to enhancing its sustainability practices and has outlined its greenhouse gas reduction goals in its corporate responsibility reports. These initiatives reflect IDEXX's dedication to addressing climate change and reducing its carbon footprint in the veterinary diagnostics industry.
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | 00,000,000 | 00,000,000 | 00,000,000 | - | - | - |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Idexx Laboratories has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

